239 related articles for article (PubMed ID: 27048459)
1. Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance.
Li R; Yang ZG; Wen LY; Liu X; Xu HY; Zhang Q; Guo YK
J Cardiovasc Magn Reson; 2016 Apr; 18():16. PubMed ID: 27048459
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast-enhanced cardiovascular magnetic resonance study.
Liu X; Yang ZG; Gao Y; Xie LJ; Jiang L; Hu BY; Diao KY; Shi K; Xu HY; Shen MT; Ren Y; Guo YK
Cardiovasc Diabetol; 2018 Oct; 17(1):139. PubMed ID: 30373588
[TBL] [Abstract][Full Text] [Related]
3. Myocardial Deformation in Cardiac Amyloid Light-chain Amyloidosis: Assessed with 3T Cardiovascular Magnetic Resonance Feature Tracking.
Li R; Yang ZG; Xu HY; Shi K; Liu X; Diao KY; Guo YK
Sci Rep; 2017 Jun; 7(1):3794. PubMed ID: 28630445
[TBL] [Abstract][Full Text] [Related]
4. The additive effects of obesity on myocardial microcirculation in diabetic individuals: a cardiac magnetic resonance first-pass perfusion study.
Jiang L; Shi K; Guo YK; Ren Y; Li ZL; Xia CC; Li L; Liu X; Xie LJ; Gao Y; Shen MT; Deng MY; Yang ZG
Cardiovasc Diabetol; 2020 May; 19(1):52. PubMed ID: 32375795
[TBL] [Abstract][Full Text] [Related]
5. Impact of pretransplant T2DM on left ventricular deformation and myocardial perfusion in heart transplanted recipients: a 3.0 T cardiac magnetic resonance study.
Cao L; Liu C; Ou C; Ma Q; Xu H; Li X; Bao Y; Chen R; Yang Y; Wu M; Liu H
Cardiovasc Diabetol; 2024 Jun; 23(1):216. PubMed ID: 38907259
[TBL] [Abstract][Full Text] [Related]
6. The additive effects of type 2 diabetes mellitus on left ventricular deformation and myocardial perfusion in essential hypertension: a 3.0 T cardiac magnetic resonance study.
Li XM; Jiang L; Guo YK; Ren Y; Han PL; Peng LQ; Shi R; Yan WF; Yang ZG
Cardiovasc Diabetol; 2020 Sep; 19(1):161. PubMed ID: 32998742
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of light-chain cardiac amyloidosis from hypertrophic cardiomyopathy using myocardial mechanical parameters by velocity vector imaging echocardiography.
Zhang L; Zhou X; Wang J; Mu Y; Liu B; Lv W; Wang Y; Liu H; Liu H; Zhi G
Int J Cardiovasc Imaging; 2017 Apr; 33(4):499-507. PubMed ID: 27878699
[TBL] [Abstract][Full Text] [Related]
8. Novel implementation of cardiac magnetic resonance first-pass perfusion imaging for semi-quantitatively evaluating microvascular dysfunction in paediatric patients with Duchenne muscular dystrophy.
Xie L; Cai X; Guo Y; Yu L; Li X; Fu C; Xu K; Song Y; Xu R; Liu H; Xu H
Br J Radiol; 2024 Jan; 97(1153):249-257. PubMed ID: 38263818
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A
Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287
[TBL] [Abstract][Full Text] [Related]
10. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
11. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.
Ternacle J; Bodez D; Guellich A; Audureau E; Rappeneau S; Lim P; Radu C; Guendouz S; Couetil JP; Benhaiem N; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Mohty D; Deux JF; Damy T
JACC Cardiovasc Imaging; 2016 Feb; 9(2):126-38. PubMed ID: 26777222
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic study.
Pradel S; Magne J; Jaccard A; Fadel BM; Boulogne C; Salemi VMC; Damy T; Aboyans V; Mohty D
Int J Cardiovasc Imaging; 2019 May; 35(5):845-854. PubMed ID: 30623354
[TBL] [Abstract][Full Text] [Related]
13. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.
Xu HY; Yang ZG; Sun JY; Wen LY; Zhang G; Zhang S; Guo YK
Eur J Radiol; 2014 Apr; 83(4):665-72. PubMed ID: 24521610
[TBL] [Abstract][Full Text] [Related]
14. The major factor of left ventricular systolic dysfunction in patients with cardiac amyloidosis: Amyloid overload or microcirculation impairment?
Lu J; Zhao P; Qiao J; Yang Z; Tang D; Zhou X; Huang L; Xia L
Front Cardiovasc Med; 2023; 10():1096130. PubMed ID: 36776256
[TBL] [Abstract][Full Text] [Related]
15. Incremental effect of coronary obstruction on myocardial microvascular dysfunction in type 2 diabetes mellitus patients evaluated by first-pass perfusion CMR study.
Wang J; Yang ZG; Guo YK; Jiang Y; Yan WF; Qian WL; Fang H; Min CY; Li Y
Cardiovasc Diabetol; 2023 Jun; 22(1):154. PubMed ID: 37381007
[TBL] [Abstract][Full Text] [Related]
16. Microvascular Dysfunction in Dilated Cardiomyopathy: A Quantitative Stress Perfusion Cardiovascular Magnetic Resonance Study.
Gulati A; Ismail TF; Ali A; Hsu LY; Gonçalves C; Ismail NA; Krishnathasan K; Davendralingam N; Ferreira P; Halliday BP; Jones DA; Wage R; Newsome S; Gatehouse P; Firmin D; Jabbour A; Assomull RG; Mathur A; Pennell DJ; Arai AE; Prasad SK
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1699-1708. PubMed ID: 30660522
[TBL] [Abstract][Full Text] [Related]
17. Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease.
Levelt E; Piechnik SK; Liu A; Wijesurendra RS; Mahmod M; Ariga R; Francis JM; Greiser A; Clarke K; Neubauer S; Ferreira VM; Karamitsos TD
J Cardiovasc Magn Reson; 2017 Oct; 19(1):81. PubMed ID: 29070069
[TBL] [Abstract][Full Text] [Related]
18. Intraventricular dyssynchrony in light chain amyloidosis: a new mechanism of systolic dysfunction assessed by 3-dimensional echocardiography.
Migrino RQ; Harmann L; Woods T; Bright M; Truran S; Hari P
Cardiovasc Ultrasound; 2008 Aug; 6():40. PubMed ID: 18687125
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
[TBL] [Abstract][Full Text] [Related]
20. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
